Background: Primary human papillomavirus (HPV) cervical screening is due to be
| BACKGROUND
Persistent infection with high-risk human papillomavirus (hrHPV) subtypes has been identified as the main etiological cause of cervical cancer (CC) 1 . In England, HPV features in 2 components of CC prevention: should be adopted nationally, 2 with plans for national implementation in England by 2019 3 .
The benefits of primary HPV testing include significantly higher sensitivity than cytology at detecting cervical intraepithelial neoplasia, 4 ,5 automated testing resulting in higher throughput of specimens and fewer human resources, and potentially increasing the screening interval from 3 to 5 years. 6 However, the specificity of HPV testing is lower than cytology due to the high prevalence of hrHPV in the young sexually active population 7, 8 ; positivity rates of 34.6% have been reported in women aged 16 to 24 years in England, 9 although this projected to fall when the vaccinated cohort commences screening. 10 The acceptability to women of HPV testing in the context of cervical screening (CS) is not clear. Hendry et al found that HPV testing in the form of HPV triage and TOC were acceptable in hypothetical situations, but concerns were still raised over receiving a positive result. 11 Having an hrHPV diagnosis has been found to result in increased anxiety and distress levels. 12 It is unclear whether the associated negative emotions are long lasting, 13 and Irish studies have suggested that it is an abnormal result rather than the HPV test itself which results in heightened anxiety levels. 14, 15 Australian and Canadian studies have
shown that a high percentage of women (78% and 84%, respectively) are willing to accept the change to primary HPV testing from cytology, 16,17 but both studies found that acceptance rates reduced significantly with the proposed extended screen intervals.
Knowledge of HPV and the natural history of CC will be central in influencing not only the acceptance of the hrHPV test but the accompanying changes in the screening program. Human papillomavirus knowledge levels in the general population have been shown to be poor. 18 The introduction of primary HPV screening will result in a dramatic increase in the number of women receiving a positive HPV result, and without adequate knowledge to interpret it, there is the potential for greater numbers of women to experience adverse psychological reactions.
This study provides an update on the attitudes of English women toward HPV infection and more specifically in the context of primary HPV testing, prior to the planned changes to the English CS program.
The aim of this study was to explore women's awareness and attitudes toward current HPV testing and primary HPV screening in England.
| METHODS
Ethical approval for the study was obtained from the London Bromley research ethics committee (15/LO/0249). Participants were recruited from 2 settings, colposcopy clinics and the community (to sample both women who had and had not experienced abnormal smear results), from across the Midlands (Leicester, Northampton, and Birmingham),
between April 2015 and December 2016. The women were asked to participate as part of a larger study exploring CS behaviors and attitudes in English-born and Eastern European migrant populations. A snowballing approach was adopted to recruit women from community groups/centers, for example, neighborhood groups. Only women of CS age in England (25-65 years) were included in the study.
The women were given the option of participating in a 1-to-1 semistructured interview or a focus group session; preliminary work suggested that some women would be more comfortable discussing this topic in a group setting. Written consent was obtained from all participants. The same interview guide (online Supporting Information) and interviewer (HP) were used for both. Interviews were conducted until data saturation was achieved.
The interviews were audio recorded and transcribed verbatim. HP reviewed the remaining transcripts to which the codes were applied. New emerging codes were added to the analytic framework, and the final framework was applied to all the transcripts. The final set of codes were grouped into themes. 19 
| RESULTS
Forty 1-to-1 semistructured interviews (mean length 30 min, range 17-58 min) and 1 focus group session (38 min) consisting of 6 community participants who were unknown to each other were conducted.
Participant characteristics are presented in Table 1 , and no differences were noted between the 2 ethnic groups; therefore, this is not referred to further in the results. Details in parentheses following quotes represent the participant's identification number, recruitment setting (PC, community; PH, colposcopy clinic), and age (in years).
| Awareness and attitudes toward current HPV testing
Most women were not aware that HPV testing was incorporated into the current NHS CS program. One participant believed it to part of a routine sexually transmitted infection (STI) screen that her daughter had been tested for. Some women were only aware that they had been tested when they received the results letter with a positive HPV result.
"My daughter's been tested for it and so have all her friends, they're all quite into being tested for that." (PC13, 56).

"I had a positive HPV and abnormal cells, so at the doctor's, like, I wasn't told, or the nurse, I wasn't told what HPV would mean" (PH7, 25).
The women held contrasting opinions regarding if they would still attend for screening knowing it involved HPV testing. Several women compared it with pregnancy when you are happy to undergo tests for conditions that you know you are unlikely to have. Women who were in long-term relationships had polarized attitudes, either they would not mind attending as they were confident that "nothing would be found" or that they would no longer feel the need to attend as HPV would not affect them.
"As in I was positive she wasn't going to find anything." (PC7, 30).
"I'm a bit more like, "oh why am I going?"" (PC22, 31). 
| Positive HPV result
Women who had not received a positive HPV result hypothesized that they would handle it in very pragmatic terms. For those who had actually tested positive for HPV, it was a different scenario. A few women
were only concerned about the fact that they had an "abnormal" result not the HPV status specifically. However, most women expressed emotions of shock, fear, and embarrassment. These were coupled with an element of self-blame for putting themself into a "high-risk" situa- 
| Participation with primary HPV testing
Some of the women, who were willing to accept that primary HPV testing was CS and for the benefit of their own health, anticipated that they would still participate. This group were very matter of fact about it, commenting that they were sexually active and therefore at potential risk of acquiring the infection and this was a test for cancer, which could be life threatening.
"No, because they are still checking for cancer so it doesn't bother me, I would still go" (PC26, 35).
The views of women in committed long-term relationships were split; some believed that they might have acquired the infection from a previous relationship and therefore would not mind participating.
Whereas others considered that testing for HPV in any form was not applicable to them, as their self-perceived risk of acquiring the infection was believed to be nonexistent. The wording of the smear invitation letter for primary HPV testing was considered important. If it was worded, for example, as "you are being invited for a cervical screening test," it may not be viewed any differently to how it is currently. However, if it mentioned that screening would involve being tested for HPV and then somewhere in the letter it was mentioned that HPV is an STI, this could deter women from attending. Even if in the letter it did not explicitly state that HPV is an STI, the women were concerned that as soon as the word HPV is entered into an internet search engine, this would be the first piece of information to appear. Currently, having a smear test is not associated with an STI.
It emerged that the information leaflet, which accompanies the smear invitation, is rarely read; therefore, the role it would play in providing information and reassurance would be limited. The stigma of being tested for HPV was thought to be lessened if men were also offered routine testing, as is the case for other STIs. 
| Division into 2 groups
There was a fear that primary HPV testing might result in women being divided into 2 groups by society, with those who attend for screening being thought of as having adopted a more high-risk lifestyle compared with nonattenders. There was concern that having CS would be viewed as synonymous with being screened for an STI. This was thought to be more of a concern for the younger generation.
"Some people who think that their husbands are unfaithful or are promiscuous and people who aren't, yes…" (PC9, 33).
| Partner feelings
The actual or hypothesized feelings of their partners regarding HPV testing in general, or about receiving a positive HPV result, were discussed. Some women found that their partners were very supportive and were only concerned about the wellbeing of the women. These partners did not question previous relationships. Other women believed that their partner's reaction to a positive HPV result would be to start questioning the faithfulness of the woman. One lady, who had previously had a positive HPV result, became distressed during the interview discussing her partner's response to it. She felt that, since the diagnosis, he was distant from her. The partners were felt to have very little knowledge about HPV and how it affects them. The male partner, in some instances, was thought to be a barrier to participation with primary HPV testing, whereas others believed it was not their decision to make. 
| Need for continued screening following a negative smear result
The women questioned the need for continued screening following a negative HPV result, if they were in a monogamous relationship.
Further, if they did attend, would it imply lack of trust in their relationship and what would be the implications of a subsequent positive result? The participants thought that this might cause confusion and that women might start to question their need for repeated screening.
"I would know that, assuming I hadn't been unfaithful, that [partner's name] must have got it from somewhere and it doesn't just appear does it? It's got to be got from someone and also then, gosh this is a bit of a moral maze isn't it…" (PC9, 33).
"…if you only go for one and you've got the same sexual partner you don't need to go for any more smears.." (PC22, 31).
| DISCUSSION
The women in this study were all of screening age and all reported participating in the screening program. Despite this, their responses reveal misunderstandings with HPV testing and very real concerns with the implications of HPV testing.
Crucially, most of the women in our study were unaware that hrHPV testing is currently part of the screening process. Therefore, the question of whether HPV testing is acceptable in its current form is difficult to answer. The issue of consent comes into question in this situation; if women are not aware what they are being tested for, it is not clear if they are providing informed consent. Human papillomavirus-related information is provided in the leaflet that accompanies the smear invitation letter; our study would suggest that either women are not reading the leaflet or they are not retaining the information.
The medium through which information is shared is important, leaflets in isolation have been found to be of little benefit, but in combination with verbal communication can improve patient experience. 20 One solution to ensure informed consent might be through verbal communication of HPV-related information at the time of the smear test.
Knowledge of HPV/HPV testing in practice nurses in England (who perform most smear tests) has been found to be poor, 21 and therefore, health-care professionals themselves will have to be educated about HPV first.
The question of if women would still attend for screening knowing that it might include an HPV test related back to their self-perceived risk of testing positive for HPV and/or their understanding of the test.
In common with other studies, a positive HPV result was associated with anxiety and distress, 12 embarrassment, and concerns about past and future sexual relationships. 22 Knowledge of HPV, which is poor among the general population, 18 was vital in calculating self-perceived risk and in the interpretation of a positive result. The influences of religious and cultural beliefs were not specifically explored in this study;
however, for women from particular cultural and religious backgrounds, HPV testing does represent a conflict. 23 Participants in this study alluded to the fact that their lifestyle choices, ie, being in a monogamous relationship, were determined by their religious beliefs and as a result believed that HPV testing was not pertinent to them. This is of great concern, as the change to primary HPV screening might result in women from particular religious backgrounds opting out of screening. Participation with primary HPV testing was discussed in hypothetical terms. For women who had had an abnormal smear result (with or without HPV) and/or undergone treatment, the fear of developing cancer was worse than the screening test. Anxiety associated with abnormal cytology and/or treatment has been shown to outweigh any concerns regarding HPV status specifically. 14 Primary HPV testing will result in a greater number of women receiving what might be considered an "abnormal" result, ie, a positive HPV result. In England between 2015 and 2016, 93.8% of all smear samples were classified as negative cytology, whereas the prevalence of hrHPV has been shown to be 27% in women aged 20 to 30 years 24 and 34.6% in 16 to 24 year olds. 9 Consequently, more women might experience adverse psychological effects, and it is unknown if women, who are cytology negative but HPV positive, will be content to wait 12 months without any treatment, as is proposed in the primary HPV screening protocol. 25 If HPV is considered to be the same as other STIs, there might be an expectation to receive treatment for it. The aforementioned practice nurse study showed that 63% believed that HPV infection requires treatment, 21 and unpublished data from another study we have conducted indicated that 76% (n = 158/208) of women share the same belief.
The marketing of primary HPV testing will be vital; this study cohort considered focusing on the prevention of CC rather than testing for HPV would help increase participation, and others have found that this may similarly reduce adverse psychological effects associated with HPV testing. 26 The difficulty will be achieving the right balance between ensuring that the women are fully aware of what they are being tested for to obtain informed consent but not taking the focus away from CC prevention. 
| Clinical implications
In England, no sudden decline in screening coverage was noted following the introduction of HPV triage and TOC
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; this study would suggest that this is because women are not actually aware that HPV is currently being tested for. When women were informed of the nature/ transmission of HPV, not all were keen on participation with HPV testing. Therefore, it is possible that the introduction of primary HPV screening might result in a significant fall in screening coverage. To combat this potential decline in participation with CS, health-care professionals will need to provide women with adequate counselling about HPV testing, for example, informing them that HPV is a very common infection. Additionally, to minimize the adverse social and/or psychological response to receiving a positive result or even just participating with primary HPV testing, clinicians will need to ensure that they provide an opportunity for patients to raise their concerns. They might even, as a routine, need to initiate such conversation and offer support, therefore taking away the onus from the patient who might not be comfortable broaching the subject.
| LIMITATIONS
Attitudes toward, and acceptability of primary HPV testing, are explored in hypothetical terms only, and it might be that once primary HPV testing is universal for all women, their opinions may differ. This study provides an insight into some of the barriers and challenges, which might be encountered on the introduction of primary HPV testing. In doing so, it presents an opportunity for health-care professionals and program implementers to be prepared and possibly even devise solutions. This study did not specifically explore the effect of culture and religion; however, other studies have explored the impact of this on attitudes toward HPV testing, in the form of HPV triage and TOC. 23, 27 It is likely that the barriers noted in these studies will be amplified with primary HPV testing, as all women will undergo HPV testing, compared with the current screening protocol, where only a limited number of women are tested. Similar to other qualitative studies, the importance and/or the generalizability of the emergent themes is not clear. Using a snowballing technique to recruit community participants might have resulted in women with similar characteristics and attitudes being recruited; however, different geographical locations were sampled in attempt to combat this. 
| CONCLUSIONS
